An essential role for adenosine signaling in alcohol abuse

Current Drug Abuse Reviews

Volumn 3, Issue 3, 2010, Pages 163-174

  Ruby, Christina L ^a   Adams, Chelsea A ^a   Knight, Emily J ^a   Nam, Hyung Wook ^a   Choi, Doo Sup ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b Department of Psychiatry and Psychology ^*  (United States)

Author keywords

Adenosine; Alcoholism; Ataxia; Genetics; Glutamate; Neuro glial interaction; Pharmacology; Signaling

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR; CYCLOHEXYLADENOSINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; SNARE PROTEIN; ALCOHOL; NUCLEOSIDE TRANSPORTER;

4 AMINOBUTYRIC ACID RELEASE; ADENOSINE BRAIN LEVEL; ALCOHOL ABUSE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; ASTROCYTE; ATAXIA; BRAIN LEVEL; BRAIN REGION; CELL INTERACTION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; NERVE CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEIC ACID METABOLISM; NUCLEIC ACID TRANSPORT; PATHOGENESIS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEIZURE; TREMOR; ALCOHOL INTOXICATION; ANIMAL; BRAIN; DRINKING BEHAVIOR; DRUG EFFECT; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE; ALCOHOL DRINKING; ALCOHOLIC INTOXICATION; ALCOHOLISM; ANIMALS; ASTROCYTES; BRAIN; ETHANOL; HUMANS; NUCLEOSIDE TRANSPORT PROTEINS; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION;

EID: 79952183660     PISSN: 18744737     EISSN: 18744745     Source Type: Journal    
DOI: 10.2174/1874473711003030163     Document Type: Article

References (142)

1. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 2006; 27: 166-76.
2. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 2008; 7: 575-90.
3. Latini S, Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 2001; 79: 463-84.
4. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001; 24: 31-55.
5. Chen J, Nam HW, Lee MR, et al. Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1. Behav Brain Res 2010; 208: 636-42.
6. Choi DS, Cascini MG, Mailliard W, et al. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 2004; 7: 855-61.
7. Nam HW, Lee MR, Hinton DJ, Choi DS. Reduced effect of NMDA glutamate receptor antagonist on ethanol-induced ataxia and striatal glutamate levels in mice lacking ENT1. Neurosci Lett 2010; 479: 277-81.
8. Hamilton NB, Attwell D. Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci 2010; 11: 227-38.
9. Peng L, Huang R, Yu AC, et al. Nucleoside transporter expression and function in cultured mouse astrocytes. Glia 2005; 52: 25-35.
10. Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999; 22: 208-15.
11. Halassa MM, Haydon PG. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 2010; 72: 335-55.
12. Pascual O, Casper KB, Kubera C, et al. Astrocytic purinergic signaling coordinates synaptic networks. Science 2005; 310: 113-6.
13. Fredholm BB, Chen JF, Masino SA, Vaugeois JM. Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu Rev Pharmacol Toxicol 2005; 45: 385-412.
14. Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM. Adenosine and brain function. Int Rev Neurobiol 2005; 63: 191-270.
15. Harvey J, Lacey MG. A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J Neurosci 1997; 17: 5271-80.
16. Manzoni OJ, Manabe T, Nicoll RA. Release of adenosine by activation of NMDA receptors in the hippocampus. Science 1994; 265: 2098-101.
17. Brundege JM, Diao L, Proctor WR, Dunwiddie TV. The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus. Neuropharmacology 1997; 36: 1201-10.
18. Fredholm BB, Fried G, Hedqvist P. Origin of adenosine released from rat vas deferens by nerve stimulation. Eur J Pharmacol 1982; 79: 233-43.
19. White TD. Direct detection of depolarisation-induced release of ATP from a synaptosomal preparation. Nature 1977; 267: 67-8.
20. Parkinson FE, Xiong W, Zamzow CR. Astrocytes and neurons: different roles in regulating adenosine levels. Neurol Res 2005; 27: 153-60.
21. Zamzow CR, Xiong W, Parkinson FE. Astrocytes affect the profile of purines released from cultured cortical neurons. J Neurosci Res 2008; 86: 2641-9.
22. Martin ED, Fernandez M, Perea G, et al. Adenosine released by astrocytes contributes to hypoxia-induced modulation of synaptic transmission. Glia 2007; 55: 36-45.
23. Parkinson FE, Ferguson J, Zamzow CR, Xiong W. Gene expression for enzymes and transporters involved in regulating adenosine and inosine levels in rat forebrain neurons, astrocytes and C6 glioma cells. J Neurosci Res 2006; 84: 801-8.
24. Kulik TB, Aronhime SN, Echeverry G, Beylin A, Winn HR. The relationship between oxygen and adenosine in astrocytic cultures. Glia 2010; 58: 1335-44.
25. Pedata F, Pazzagli M, Tilli S, Pepeu G. Regional differences in the electrically stimulated release of endogenous and radioactive adenosine and purine derivatives from rat brain slices. Naunyn Schmiedebergs Arch Pharmacol 1990; 342: 447-53.
26. Lloyd HG, Lindstrom K, Fredholm BB. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem Int 1993; 23: 173-85.
27. Lloyd HG, Fredholm BB. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem Int 1995; 26: 387-95.
28. Zamzow CR, Xiong W, Parkinson FE. Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes. J Neurosci Res 2008; 86: 3447-55.
29. Baldwin SA, Mackey JR, Cass CE, and Young JD. Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 1999; 5: 216-24.
30. Baldwin SA, Beal PR, Yao SY, et al. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 2004; 447: 735-43.
31. Griffiths M, Beaumont N, Yao SY, et al. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs [see comments]. Nat Med 1997; 3: 89-93.
32. Griffiths M, Yao SY, Abidi F, et al. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J 1997; 328: 739-43.
33. Yao SY, Ng AM, Muzyka WR, et al. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)- sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem 1997; 272: 28423-30.
34. Hammond JR. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity. Naunyn-Sch Arch Pharmacology 2000; 361: 373-82.
35. King AE, Ackley MA, Cass CE, Young JD, Baldwin SA. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci 2006; 27: 416-25.
36. Alanko L, Heiskanen S, Stenberg D, Porkka-Heiskanen T. Adenosine kinase and 5'-nucleotidase activity after prolonged wakefulness in the cortex and the basal forebrain of rat. Neurochem Int 2003; 42: 449-54.
37. Chagoya de Sanchez V. Circadian variations of adenosine and of its metabolism. Could adenosine be a molecular oscillator for circadian rhythms? Can J Physiol Pharmacol 1995; 73: 339-55.
38. Porkka-Heiskanen T. Adenosine in sleep and wakefulness. Ann Med 1999; 31: 125-9.
39. Sharma R, Engemann S, Sahota P, Thakkar MM. Role of adenosine and wake-promoting basal forebrain in insomnia and associated sleep disruptions caused by ethanol dependence. J Neurochem 2010; In press.
40. Thakkar MM, Engemann SC, Walsh KM, Sahota PK. Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep- wakefulness. Neuroscience 2008;153: 875-80.
41. Anderson CM, Xiong W, Geiger JD, et al. Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brain. J Neurochem 1999; 73: 867-73.
42. Jennings LI, Hao C, Cabrita MA, et al. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology 2001;10: 722-31.
43. Hyde RJ, Cass CE, Young JD, Baldwin SA. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 2001;18: 53-63.
44. Baldwin SA, Yao SY, Hyde RJ, et al. Functional characterisation of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 2005; 280: 15880-7.
45. Pinto-Duarte A, Coelho JE, Cunha RA, Ribeiro JA, Sebastiao AM. Adenosine A2A receptors control the extracellular levels of adenosine through modulation of nucleoside transporters activity in the rat hippocampus. J Neurochem 2005; 93: 595-604.
46. Smith KM, Ng AM, Yao SY, et al. Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes. J Physiol 2004; 558: 807-23.
47. Niitani M, Nishida K, Okuda H, et al. Transport characteristics of mouse concentrative nucleoside transporter 1. Int J Pharm 2010; 388: 168-74.
48. Guillen-Gomez E, Calbet M, Casado J, et al. Distribution of CNT2 and ENT1 transcripts in rat brain: selective decrease of CNT2 mRNA in the cerebral cortex of sleep-deprived rats. J Neurochem 2004; 90: 883-93.
49. Li JY, Boado RJ, Pardridge WM. Cloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2. J Cereb Blood Flow Metab 2001; 21: 929-36.
50. Kull B, Arslan G, Nilsson C, et al. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. Biochem Pharmacol 1999; 57: 65-75.
51. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-52.
52. Klotz KN, Hessling J, Hegler J, et al. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 1998; 357: 1-9.
53. Yaar R, Jones MR, Chen JF, Ravid K. Animal models for the study of adenosine receptor function. J Cell Physiol 2005; 202: 9-20.
54. van der Wenden EM, Carnielli M, Roelen HC, et al. 5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor. J Med Chem 1998; 41: 102-8.
55. Muller CE. Adenosine receptor ligands-recent developments part I. Agonists. Curr Med Chem 2000; 7: 1269-88.
56. Bruns RF, Fergus JH. Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol Pharmacol 1990; 38: 939-49.
57. Reppert SM, Weaver DR, Stehle JH, Rivkees SA. Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol 1991; 5: 1037-48.
58. Ochiishi T, Chen L, Yukawa A, et al. Cellular localization of adenosine A1 receptors in rat forebrain: immunohistochemical analysis using adenosine A1 receptor-specific monoclonal antibody. J Comp Neurol 1999; 411: 301-16.
59. Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 1996; 118: 1461-8.
60. Mahan LC, McVittie LD, Smyk-Randall EM, et al. Cloning and expression of an A1 adenosine receptor from rat brain. Mol Pharmacol 1991; 40: 1-7.
61. Johansson B, Georgiev V, Fredholm BB. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors. Neuroscience 1997; 80: 1187-207.
62. Thompson SM, Haas HL, Gahwiler BH. Comparison of the actions of adenosine at pre- and postsynaptic receptors in the rat hippocampus in vitro. J Physiol 1992; 451: 347-63.
63. Ebersolt C, Premont J, Prochiantz A, Perez M, Bockaert J. Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations. Brain Res 1983; 267: 123-9.
64. Fredholm BB. On the mechanism of action of theophylline and caffeine. Acta Med Scand 1985; 217: 149-53.
65. Linden J. Structure and function of A1 adenosine receptors. Faseb J 1991; 5: 2668-76.
66. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA 1995; 92: 4666-70.
67. Schulte G, Fredholm BB. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 2003; 15: 813-27.
68. Takigawa T, Alzheimer C. Phasic and tonic attenuation of EPSPs by inward rectifier K+ channels in rat hippocampal pyramidal cells. J Physiol 2002; 539: 67-75.
69. Johansson B, Halldner L, Dunwiddie TV, et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci USA 2001; 98: 9407-12.
70. Dar MS. Mouse cerebellar adenosinergic modulation of ethanolinduced motor incoordination: possible involvement of cAMP. Brain Res 1997; 749: 263-74.
71. Kaplan GB, Bharmal NH, Leite-Morris KA, Adams WR. Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome. Alcohol 1999; 19: 157-62.
72. Kull B, Svenningsson P, Fredholm BB. Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Mol Pharmacol 2000; 58: 771-7.
73. Sebastiao AM, Ribeiro JA. Tuning and fine-tuning of synapses with adenosine. Curr Neuropharmacol 2009; 7: 180-94.
74. Ciruela F, Casado V, Rodrigues RJ, et al. Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 2006; 26: 2080-7.
75. Ferre S, O'Connor WT, Snaprud P, Ungerstedt U, Fuxe K. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience 1994; 63: 765-73.
76. Ferre S, Quiroz C, Woods AS, et al. An update on adenosine A2A- dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr Pharm Des 2008; 14: 1468-74.
77. Mailliard WS, Diamond I. Recent advances in the neurobiology of alcoholism: the role of adenosine. Pharmacol Ther 2004; 101: 39-46.
78. Naassila M, Ledent C, Daoust M. Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. J Neurosci 2002; 22: 10487-93.
79. El Yacoubi M, Ledent C, Parmentier M, et al. Absence of the adenosine A(2A) receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice. Neuropharmacology 2001; 40: 424-32.
80. Arolfo MP, Yao L, Gordon AS, Diamond I, Janak PH. Ethanol operant self-administration in rats is regulated by adenosine A2 receptors. Alcohol Clin Exp Res 2004; 28:1308-16.
81. Linden J, Thai T, Figler H, Jin X, Robeva AS. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol 1999; 56: 705-13.
82. Stehle JH, Rivkees SA, Lee JJ, et al. Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endocrinol 1992; 6: 384-93.
83. Feoktistov I, Biaggioni I. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells coexpressing A2A and A2B adenosine receptor subtypes. Biochem Pharmacol 1998; 55: 627-33.
84. Feoktistov I, Biaggioni I. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofyllinesensitive mechanism with implications for asthma. J Clin Invest 1995; 96: 1979-86.
85. Bezzi P, Carmignoto G, Pasti L, et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998; 391: 281-5.
86. Fellin T, Pascual O, Gobbo S, et al. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 2004; 43: 729-43.
87. Coco S, Calegari F, Pravettoni E, et al. Storage and release of ATP from astrocytes in culture. J Biol Chem 2003; 278: 1354-62.
88. Mothet JP, Parent AT, Wolosker H, et al. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 2000; 97: 4926-31.
89. Halassa MM, Fellin T, Haydon PG. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 2007; 13: 54-63.
90. Rossi DJ, Brady JD, Mohr C. Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 2007; 10: 1377-86.
91. Halassa MM, Fellin T, Haydon PG. Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 2009; 57: 343-6.
92. Haydon PG, Blendy J, Moss SJ, Rob Jackson F. Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse? Neuropharmacology 2009; 56(Suppl 1): 83-90.
93. Wu J, Lee MR, Choi S, Kim T, Choi DS. ENT1 regulates ethanolsensitive EAAT2 expression and function in astrocytes. Alcohol Clin Exp Res 2010; 34: 1110-7.
94. Koob GF, and Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010; 35: 217-38.
95. Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 2009; 10: 561-72.
96. Huber R, Hill SL, Holladay C, et al. Sleep homeostasis in Drosophila melanogaster. Sleep 2004; 27: 628-39.
97. Halassa MM, Florian C, Fellin T, et al. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 2009; 61: 213-9.
98. Bjorness TE, Kelly CL, Gao T, Poffenberger V, Greene RW. Control and function of the homeostatic sleep response by adenosine A1 receptors. J Neurosci 2009; 29: 1267-76.
99. Dunwiddie TV. The physiological role of adenosine in the central nervous system. Intl Rev Neurobiol 1985; 27: 63-139.
100. Dunwiddie TV. Adenosine and suppression of seizures. Adv Neurol 1999; 79: 1001-10.
101. Dar MS. Central adenosinergic system involvement in ethanolinduced motor incoordination in mice. J Pharmacol Exp Ther 1990; 255: 1202-09.
102. Dar MS. Modulation of ethanol-induced motor incoordination by mouse striatal A(1) adenosinergic receptor. Brain Res Bull 2001; 55: 513-20.
103. Connole L, Harkin A, Maginn M. Adenosine A1 receptor blockade mimics caffeine's attenuation of ethanol-induced motor incoordination. Basic Clin Pharmacol Toxicol 2004; 95: 299-304.
104. Barwick VS, Dar MS. Adenosinergic modulation of ethanolinduced motor incoordination in the rat motor cortex. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22: 587-607.
105. Meng ZH, Dar MS. Possible role of striatal adenosine in the modulation of acute ethanol-induced motor incoordination in rats. Alcohol Clin Exp Res 1995; 19: 892-901.
106. Phan TA, Gray AM, Nyce JW. Intrastriatal adenosine A1 receptor antisense oligodeoxynucleotide blocks ethanol-induced motor incoordination. Eur J Pharmacol 1997; 323: R5-R7.
107. Dar MS, Mustafa SJ. Acute ethanol/cannabinoid-induced ataxia and its antagonism by oral/systemic/intracerebellar A1 adenosine receptor antisense in mice. Brain Res 2002; 957: 53-60.
108. Dar MS. Mouse cerebellar adenosine-glutamate interactions and modulation of ethanol-induced motor incoordination. Alcohol Clin Exp Res 2002; 26: 1395-403.
109. Sichardt K, Nieber K. Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain. Purinergic Signal 2007; 3: 285-98.
110. Moore MS, DeZazzo J, Luk AY, et al. Ethanol intoxication in Drosophila: Genetic and pharmacological evidence for regulation by the cAMP signaling pathway [see comments]. Cell 1998; 93: 997-1007.
111. Wand G, Levine M, Zweifel L, Schwindinger W, Abel T. The cAMP-protein kinase A signal transduction pathway modulates ethanol consumption and sedative effects of ethanol. J Neurosci 2001; 21: 5297-303.
112. Faure M, Voyno-Yasenetskaya TA, Bourne HR. cAMP and bg subunits of heterotrimeric G proteins stimulate the mitogenactivated protein kinase pathway in COS-7 cells. J Biol Chem 1994; 269: 7851-54.
113. Dickenson JM, Hill SJ. Human 5-HT1B receptor stimulated inositol phospholipid hydrolysis in CHO cells: synergy with Gqcoupled receptors. Eur J Pharmacol 1998; 348: 279-85.
114. Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, Lefkowitz RJ. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G proteincoupled receptor-mediated Ras activation. J Biol Chem 1997; 272: 4637-44.
115. Moonat S, Starkman BG, Sakharkar A, Pandey SC. Neuroscience of alcoholism: molecular and cellular mechanisms. Cell Mol Life Sci 2010; 67: 73-88.
116. Pandey SC, Zhang H, Ugale R, et al. Effector immediate-early gene arc in the amygdala plays a critical role in alcoholism. J Neurosci 2008; 28: 2589-600.
117. Svenningsson P, Le Moine C, Kull B, et al. Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 1997; 80: 1171-85.
118. Spanagel R, Kiefer F. Drugs for relapse prevention of alcoholism: ten years of progress. Trends Pharmacol Sci 2008; 29: 109-15.
119. Tsai G, Coyle JT. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 1998; 49: 173-84.
120. Spanagel R, Heilig M. Addiction and its brain science. Addiction 2005; 100: 1813-22.
121. Spanagel R, Pendyala G, Abarca C, et al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 2005; 11: 35-42.
122. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science 1997; 278: 58-63.
123. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001; 2: 119-28.
124. Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002; 35: 605-23.
125. Kreek MJ, LaForge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov 2002; 1: 710-26.
126. Nagy LE, Diamond I, Casso DJ, Franklin C, Gordon AS. Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem 1990; 265: 1946-51.
127. Nagy LE, Diamond I, Collier K, et al. Adenosine is required for ethanol-induced heterologous desensitization. Mol Pharmacol 1989; 36: 744-48.
128. Coe I, Zhang Y, McKenzie T, Naydenova Z. PKC regulation of the human equilibrative nucleoside transporter, hENT1. FEBS Lett 2002; 517: 201-5.
129. Bone DB, Robillard KR, Stolk M, Hammond JR. Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2. Mol Membr Biol 2007; 24: 294-303.
130. Handa M, Choi DS, Caldeiro RM, et al. Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site. Gene 2001; 262: 301-7.
131. Choi DS, Handa M, Young H, et al. Genomic organization and expression of the mouse equilibrative, nitrobenzylthioinosinesensitive nucleoside transporter 1 (ENT1) gene. Biochem Biophys Res Commun 2000; 277: 200-8.
132. Pandey SC, Roy A, Zhang H, Xu T. Partial deletion of the cAMP response element-binding protein gene promotes alcohol-drinking behaviors. J Neurosci 2004; 24: 5022-30.
133. Melendez RI, Kalivas PW. Last call for adenosine transporters. Nat Neurosci 2004; 7: 795-6.
134. Othman T, Sinclair CJ, Haughey N, Geiger JD, Parkinson FE. Ethanol alters glutamate but not adenosine uptake in rat astrocytes: evidence for protein kinase C involvement. Neurochem Res 2002; 27: 289-96.
135. Bell RL, Kimpel MW, McClintick JN, et al. Gene expression changes in the nucleus accumbens of alcohol-preferring rats following chronic ethanol consumption. Pharmacol Biochem Behav 2009; 94: 131-47.
136. Short JL, Ledent C, Borrelli E., Drago J, Lawrence AJ. Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice. Neuroscience 2006;139; 661-70.
137. Gass N, Ollila HM, Utge S, et al. Contribution of adenosine related genes to the risk of depression with disturbed sleep. J Affect Disord 2010; 126: 134-9.
138. Lu G, Zhou QX, Kang S, et al. Chronic morphine treatment impaired hippocampal long-term potentiation and spatial memory via accumulation of extracellular adenosine acting on adenosine A1 receptors. J Neurosci 2010; 30: 5058-70.
139. Levran O, Londono D, O'Hara K, et al. Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav 2009; 8: 531-40.
140. Kachroo A, Orlando LR, Grandy DK, et al. Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J Neurosci 2005; 25: 10414-9.
141. Schwarzschild MA, Agnati L, Fuxe K, Chen JF, Morelli M. Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci 2006; 29: 647-54.
142. Gianfriddo M, Melani A, Turchi D, Giovannini MG, Pedata F. Adenosine and glutamate extracellular concentrations and mitogenactivated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow. Neurobiol Dis 2004; 17: 77-88.